According to Fosun Pharmaceutical's announcement, the holding subsidiary Fosun Pharma Singapore Company sold 9.897 million shares of GlandPharma through bulk transactions and centralized bidding, accounting for 6.00% of its total share capital, with a total transaction consideration of about US$294 million.

According to Fosun Pharmaceutical's announcement, the holding subsidiary Fosun Pharma Singapore Company sold 9.897 million shares of GlandPharma through bulk transactions and centralized bidding, accounting for 6.00% of its total share capital, with a total transaction consideration of about US$294 million.